J, M., JS, G., DA, P., & CD, D. (2024). Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go? American journal of hematology, 99(9), 1790. https://doi.org/10.1002/ajh.27434
Chicago Style (17th ed.) CitationJ, Marvin-Peek, Gilbert JS, Pollyea DA, and DiNardo CD. "Frontline Therapy of Acute Myeloid Leukemia with Lower Intensity Regimens: Where Are We Now and Where Can We Go?" American Journal of Hematology 99, no. 9 (2024): 1790. https://doi.org/10.1002/ajh.27434.
MLA (9th ed.) CitationJ, Marvin-Peek, et al. "Frontline Therapy of Acute Myeloid Leukemia with Lower Intensity Regimens: Where Are We Now and Where Can We Go?" American Journal of Hematology, vol. 99, no. 9, 2024, p. 1790, https://doi.org/10.1002/ajh.27434.